GSK wins U.S. nod for two-drug HIV combination
GlaxoSmithKline Plc's two-drug treatment for HIV infections won U.S. market approval on Monday, boosting the British drugmaker's growth prospects against competitor Gilead Sciences Inc.
from Reuters: Health News https://reut.rs/2ImBUNU
http://bit.ly/2zwRqiM